Skip to Main Content

Author Details

Ralf Kemmerling
Institute of Pathology, Paracelsus Medical University
2000
29
15
PMIDPaper TitleJournal TitlePublished Year
31167495Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma.Cells2019
31167495Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma.Cells2019
25524262Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.Gut2016
25524262Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.Gut2016
27123276Back to the start: Evaluation of prognostic markers in gastrointestinal stromal tumors.Mol Clin Oncol2016
27123276Back to the start: Evaluation of prognostic markers in gastrointestinal stromal tumors.Mol Clin Oncol2016
24798743Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.Leuk Lymphoma2015
26504039Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic Regulations.Anticancer Res2015
26206335Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.Mol Cancer Ther2015
24798743Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.Leuk Lymphoma2015
26504039Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic Regulations.Anticancer Res2015
26206335Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.Mol Cancer Ther2015
24527082Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors.Oncol Lett2014
24527082Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors.Oncol Lett2014
23271725Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma.Cancer Res2013
23271725Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma.Cancer Res2013
23466801Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment.J Photochem Photobiol B2013
23255907The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models.Oncol Lett2013
23466801Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment.J Photochem Photobiol B2013
23255907The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models.Oncol Lett2013
21605074Current status of therapeutic targeting of developmental signalling pathways in oncology.Curr Pharm Biotechnol2012
22334367A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps.Genes Chromosomes Cancer2012
22614781Association of stem cell marker expression pattern and survival in human biliary tract cancer.Int J Oncol2012
21605074Current status of therapeutic targeting of developmental signalling pathways in oncology.Curr Pharm Biotechnol2012
22614781Association of stem cell marker expression pattern and survival in human biliary tract cancer.Int J Oncol2012
22334367A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps.Genes Chromosomes Cancer2012
21435437Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Am J Pathol2011
21435437Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Am J Pathol2011
21730268Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.J Clin Oncol2011
21629744Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?J Biomed Biotechnol2011
21807546Another case of diethyl ether intoxication?: a case report focusing on toxicological analysis.Leg Med (Tokyo)2011
21998336Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.Clin Cancer Res2011
21656271Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue.Cell Oncol (Dordr)2011
21998336Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.Clin Cancer Res2011
21807546Another case of diethyl ether intoxication?: a case report focusing on toxicological analysis.Leg Med (Tokyo)2011
21629744Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?J Biomed Biotechnol2011
21656271Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue.Cell Oncol (Dordr)2011
21730268Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.J Clin Oncol2011
19910107Invasive aspergillosis presenting with a painless complete ophthalmoplegia.Clin Neurol Neurosurg2010
20966547Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue.Anal Cell Pathol (Amst)2010
20372839Primary testicular lymphoma: a strictly homogeneous hematological disease?Oncol Rep2010
19910107Invasive aspergillosis presenting with a painless complete ophthalmoplegia.Clin Neurol Neurosurg2010
20966547Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue.Anal Cell Pathol (Amst)2010
20372839Primary testicular lymphoma: a strictly homogeneous hematological disease?Oncol Rep2010
18774962Increased activated Akt expression in renal cell carcinomas and prognosis.J Cell Mol Med2009
19155147Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.Pathol Res Pract2009
18774962Increased activated Akt expression in renal cell carcinomas and prognosis.J Cell Mol Med2009
19155147Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.Pathol Res Pract2009
19669201Differential diagnostic challenge of chronic neutrophilic leukemia in a patient with prolonged leukocytosis.J Hematop2008
19669201Differential diagnostic challenge of chronic neutrophilic leukemia in a patient with prolonged leukocytosis.J Hematop2008
  • 1 - 50 of 58

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 3
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
Bernadette Liegl-Atzwanger
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 0
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
Jaime Ferrer
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 0
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 0
Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
Career Start Year 1996
Number of shared co-authors 1
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 1
Gerrit A Meijer
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 3
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 3
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 1
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 1
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 1
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 0
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 4
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 2
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 0
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 1
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Co-authored papers 5
Thomas Ried
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Jordi Camps
Universitat Autonoma de Barcelona
Co-authored papers 3
Patrizia Moser
Medical University of Innsbruck
Co-authored papers 3
Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Co-authored papers 2
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Ren?? G Feichtinger
Paracelsus Medical University
Co-authored papers 1
Danny Wangsa
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Mark Stapleton
Lawrence Berkeley National Laboratory
Co-authored papers 1
Johannes A Mayr
University Children's Hospital, Paracelsus Medical University
Co-authored papers 1
Hans A Kestler
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Kristjan Plaetzer
Paris Lodron University of Salzburg
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Release 1.2